In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

A Dallas-based biotech company that announced the rebirth of the dire wolf, which was popularized in "Game of Thrones," also has cloned the endangered red wolf. This week, Colossal Biosciences ...

The Basel Area in Switzerland is home to one of Europe’s brightest biotech ecosystems. Over the years, it has proven to be the favored location for many of the world’s biggest, best, and newest ...

American biotech company Colossal Biosciences made ... as a way to get people talking about wolves and saving the critically endangered red wolf. On that front, the private, Dallas-based company ...

Over the last week, LabCentral announced a CEO transition, a new Cambridge biotech launched with a megaround and Tango Therapeutics disclosed layoffs. Over the last week, LabCentral announced a ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

FAYETTEVILLE — Bobby Petrino is starting his second season as offensive coordinator for Arkansas. A position that has caught his attention is running back. Braylen Russell is among the returning ...

A biotech company says it has bred three animals ... Colossal also announced that it had bred four cloned red wolves, the most endangered wolf species in the world, and said its technology could ...

Stainless Steel sales volumes grow 13% YoY and drop 23% MoM to 6,619 MT Stainless Steel average realisations increase 1% YoY and decline 1% MoM to Rs 1.28 lakh per MT Aluminium foil sales volumes ...

The U.S.-based biotechnology company is also known for ... Colossal Biosciences Colossal also said it had cloned four red wolves, a critically endangered animal with under two dozen thought ...

After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived. From cautious employers to ...